Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Cambodian Phellinus linteus inhibits experimental metastasis of melanoma cells in mice via regulation of urokinase type plasminogen activator.

Lee HJ, Lee HJ, Lim ES, Ahn KS, Shim BS, Kim HM, Gong SJ, Kim DK, Kim SH.

Biol Pharm Bull. 2005 Jan;28(1):27-31.

2.

Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.

Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.

Int J Oncol. 2006 Apr;28(4):807-14.

PMID:
16525628
3.

Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma.

Eitzman DT, Krauss JC, Shen T, Cui J, Ginsburg.

Blood. 1996 Jun 1;87(11):4718-22.

4.
5.

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.

Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, Park RW, Onn A, Herbst RS, Li C, Lee HY.

Mol Cancer Ther. 2006 Nov;5(11):2685-95.

6.
7.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

8.

The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis.

Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH, Kim HM.

Immunopharmacology. 1999 Feb;41(2):157-64.

PMID:
10102797
9.

Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways.

Huang GJ, Yang CM, Chang YS, Amagaya S, Wang HC, Hou WC, Huang SS, Hu ML.

J Agric Food Chem. 2010 Sep 8;58(17):9468-75. doi: 10.1021/jf101508r.

PMID:
20698552
11.
12.

Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.

Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.

Cancer Res. 2007 Jan 1;67(1):9-15.

13.

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

Hearing VJ, Law LW, Corti A, Appella E, Blasi F.

Cancer Res. 1988 Mar 1;48(5):1270-8.

14.
17.
18.

How platelet aggregation affects B16BL6 melanoma cell trafficking.

Koike C, Watanabe M, Isoai A, Kumagai H, Tsukada H, Irimura T, Okada S, Oku N.

FEBS Lett. 1998 May 8;427(2):286-90.

19.

In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells.

Chu SC, Yang SF, Liu SJ, Kuo WH, Chang YZ, Hsieh YS.

Food Chem Toxicol. 2007 Jul;45(7):1194-201. Epub 2007 Jan 11.

PMID:
17303298
20.

Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.

Bianchini F, D'Alessio S, Fibbi G, Del Rosso M, Calorini L.

Oncol Rep. 2006 Mar;15(3):709-14.

PMID:
16465434

Supplemental Content

Support Center